Comprehensive Guide to Mutation Detection and Cytogenetic Methods

Overview of Mutation Detection Methods

  • General Purpose of Detection Methods

    • Used to test for inherited disorders and diseases resulting from acquired genetic alterations.

    • Provide critical information for clinical evaluation, diagnosis, tailoring specific therapies, and determining prognosis.

  • Primary Categories of Testing

    • Mutation detection for known mutations: Evaluating specific, predefined sequence changes at the DNA level.

    • Cytogenetic studies: Detecting larger variations and structural rearrangements at the chromosome level.

    • Genotyping methods: Used to discover mutations and perform genetic testing (Direct vs. Indirect/Linkage analysis).

Mutation Detection of Known Mutations

  • Definition and Scope

    • Detects variation specifically at the DNA level.

    • Focuses on evaluating a known sequence change.

    • Targets a predefined number of sequence changes based on the clinical phenotypes of the patient.

    • Primary examples include Protein Electrophoresis, Polymerase Chain Reaction (PCR), and Microarray.

  • Protein Electrophoresis

    • Mechanism: A method of separating proteins based on size and electrical charge. A sample is placed in a gel media and subjected to an electrical charge. Proteins carry slight differences in charge, causing them to move through the media at varying paces depending on their size.

    • The Process of Gel Electrophoresis:

      1. Restriction Enzymes: These enzymes cleave the DNA sample into smaller segments of various sizes.

      2. Loading: DNA segments are loaded into wells in a porous gel. The gel floats in a buffer solution within a chamber between two electrodes.

      3. Migration: When an electric current is passed through the chamber, DNA fragments move toward the positively-charged cathode.

      4. Separation: Smaller DNA segments move faster and farther through the gel than larger DNA segments.

    • Clinical Uses:

      • Evaluation of M-protein in multiple myeloma (via urine electrophoresis).

      • Analysis of specific types of leukemia and lymphoma.

      • Diagnosis of Amyloidosis and Sickle cell hemoglobin analysis.

      • Western-blot analysis: Used for HIV testing, Lyme disease, and confirming Hepatitis B and Herpes Simplex Virus (HSV) infections.

    • Advantages: Established record of detecting slight amino acid variations in human proteins; compatible with serum, urine, and cerebrospinal fluid (CSF).

    • Disadvantages: Silent substitutions (mutations that do not alter the amino acid sequence) cannot be detected via this approach.

  • Polymerase Chain Reaction (PCR)

    • Description: An invention that enables efficacious detection of genetic variations by replicating short specific DNA sequences quickly. It amplifies small amounts of DNA into millions of copies for analysis.

    • The Three-Step Cycle:

      1. Denaturation: The temperature is increased to 98 ∘C98\,^{\circ}\text{C} to separate the DNA strands.

      2. Annealing: The temperature is decreased to between 48 ∘C48\,^{\circ}\text{C} and 72 ∘C72\,^{\circ}\text{C} to allow primers to base pair to the complementary DNA template.

      3. Extension: The temperature is set between 68 ∘C68\,^{\circ}\text{C} and 72 ∘C72\,^{\circ}\text{C}. Polymerase extends the primer to form a nascent DNA strand.

    • Exponential Amplification Phases:

      • Cycle 1: 22=42^{2} = 4 copies.

      • Cycle 2: 23=82^{3} = 8 copies.

      • Cycle 3: 24=162^{4} = 16 copies.

      • Cycle 4: 25=322^{5} = 32 copies.

      • Cycle 30: results in approximately 2312^{31} (over 22 billion) copies.

    • Clinical and Practical Uses:

      • Genetic disease diagnosis and drug development.

      • Forensic medicine.

      • Identification of pathogenic organisms: Viruses, Bacteria, Parasites, and Fungi.

      • Biochemical analysis.

    • Advantages: Easy and quick process; requires only a very small quantity of DNA; targets specific mutations.

    • Disadvantages: Impractical for disorders characterized by a large number of different mutations; requires prior identification of the primary DNA sequence; highly susceptible to contamination.

  • Microarray (DNA Chips)

    • Description: Uses multiple probes on a single chip or glass slide to analyze anywhere from a few to a million single nucleotide polymorphisms (SNPs).

    • Mechanism and Gene Expression:

      • Determines which genes are "turned on" or "turned off" by assessing expression levels.

      • mRNA is extracted and used as a template to form complementary DNA (cDNA) sequences used on the slide.

    • Methodology:

      1. Preparation: Single-stranded fluorescently labeled oligonucleotides (normal and disease-causing) are placed on a silicon chip.

      2. Hybridization: Patient DNA is added to the chip to see if it hybridizes with the oligonucleotides.

      3. Comparison: mRNA is isolated from healthy and diseased cells to determine differences in expression.

      4. Scanning: The chip is scanned and analyzed for fluorescent signals.

    • Clinical Uses:

      • Oncology: BRCA 1 and BRCA 2 (breast cancer), prostate cancer, and colorectal cancer.

      • Other conditions: Cystic fibrosis, hemochromatosis, and age-related macular degeneration.

      • General medical research.

    • Advantages: Can assess thousands of genes simultaneously; identifies upregulated or downregulated genes.

    • Disadvantages: Analysis is limited to the specific genes selected and placed on the chip; cannot identify rare, previously unidentified mutations.

Cytogenetic Studies

  • Definition and Application

    • Detects variation at the chromosome level, specifically larger structural variants.

    • Indicated when the patient phenotype suggests more than just point mutations or small indels (deletions/duplications).

  • Fluorescent In Situ Hybridization (FISH)

    • Description: Relies on fluorescent-labeled DNA segments (probes) that are complementary to a specific chromosomal region.

    • Process:

      1. Preparation of Probe: A segment of chromosomal DNA of interest is fluorescently labeled.

      2. Hybridization: Denatured chromosomes on a slide are exposed to the probe; the probe attaches to its matching DNA sequence.

      3. Visualization: The slide is viewed under fluorescent lighting. Signals indicate the presence of the segment; absence of signal indicates a deletion.

    • Stages of Analysis: Can be performed during Interphase or Metaphase of cell division.

    • Examples of Visualization:

      • Trisomy 21: A pink probe is used for Chromosome 21, and a green control probe is used for Chromosome 13.

      • Deletion Detection: A green probe targets the region of interest while a pink probe acts as the control. In a deletion, the patient will show two green control signals but only one pink signal (representing the single remaining intact chromosome).

    • Advantages: Identifies large abnormalities like deletions, duplications, and translocations; useful for monitoring recurrent or residual disease in bone marrow transplant patients.

    • Disadvantages: Cannot identify small mutations/insertions; accuracy depends entirely on choosing the correct probe for the suspected condition.

Genotyping Methods

  • Direct Mutation Analysis (Known Mutations)

    • Diagnosis achieved through direct identification of a known gene mutation.

    • Examples: FISH, Microarray.

    • Advantages: Family information is not required; eliminates errors resulting from genetic recombination.

  • Indirect Diagnosis/Linkage Analysis (Unknown Mutations)

    • Description: Used to identify unknown genetic diseases or diagnose mapped genetic diseases where the specific mutation is not identified.

    • Concept of Linkage:

      • Loci occupying the same region of a chromosome are "linked."

      • Genes located near each other are transmitted together rather than independently.

    • Mechanism of Linkage Analysis:

      • Markers: Short tandem repeat sequences used to follow a disease gene through a family tree.

      • The marker identifies which chromosome segment is transmitted by the parent, even if the marker does not cause the disease itself.

      • Linkage Phase: Must be established within a family to determine if an at-risk individual inherited the disease-carrying or normal chromosome segment.

    • Clinical Uses:

      • Identification of genes linked to inherited diseases like hyperlipidemia.

      • Prenatal diagnosis of genetic diseases.

    • Advantages: The specific gene and its protein product do not need to be known; highly useful for rare disorders.

    • Disadvantages: Requires testing of multiple family members to establish the linkage phase; less effective for complex traits (e.g., diabetes) involving multiple genes.